Literature DB >> 28052365

Serum ferritin values between 300 and 800 ng/mL in nontransfusion-dependent thalassemia: A probability curve to guide clinical decision making when MRI is unavailable.

Antoine N Saliba1, Khaled M Musallam2,3, Maria D Cappellini3, Giovanna Graziadei3, Shahina Daar4, Vip Viprakasit5, Ali T Taher2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28052365     DOI: 10.1002/ajh.24628

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

Review 1.  Iron overload in thalassemia: different organs at different rates.

Authors:  Ali T Taher; Antoine N Saliba
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

2.  Serum or plasma ferritin concentration as an index of iron deficiency and overload.

Authors:  Maria Nieves Garcia-Casal; Sant-Rayn Pasricha; Ricardo X Martinez; Lucero Lopez-Perez; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

3.  Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content.

Authors:  Mohamed A Yassin; Ashraf T Soliman; Vincenzo De Sanctis; Khadra S Yassin; Mohammad Aj Abdulla
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-05-01       Impact factor: 2.576

4.  Deferasirox in thalassemia: a comparative study between an innovator drug and its copy among a sample of Iraqi patients.

Authors:  Aqil M Daher; Hayder Al-Momen; Shaymaa Kadhim Jasim
Journal:  Ther Adv Drug Saf       Date:  2019-10-09

Review 5.  Management of Iron Overload in Beta-Thalassemia Patients: Clinical Practice Update Based on Case Series.

Authors:  Valeria Maria Pinto; Gian Luca Forni
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

6.  Green tea influence on iron overload in thalassemia intermedia patients: a randomized controlled trial.

Authors:  Hayder Al-Momen; Hussein Khudhair Hussein; Zaid Al-Attar; Mohammed Jalal Hussein
Journal:  F1000Res       Date:  2020-09-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.